european-autoimmune-disease-diagnostics-market-industry
Published

August 2016

European Autoimmune Disease Diagnostics Market Growth, Trends and Forecasts (2015 - 2020)

Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license

The Europe Autoimmune Disease Diagnostic Market for the period 2015-2020 is expected to account for USD XX billion at a CAGR of XX% from USD XX billion on 2015.  Autoimmune diseases are a group of diseases characterized by inflammatory reactions caused by immune responses mistakenly generated against body tissues.

The term autoimmune disease refers to a varied group of illnesses that involve almost every human organ system. Environmental, infectious, and genetic factors play an important role in initiating or exacerbating autoimmune diseases.

The European Autoimmune Disease Market is driven by various factors like growing public awareness about the disease condition, improvement in laboratory automations, increasing partnerships between physicians and clinical laboratories and technological innovations. However, the market is restrained by the slow turnaround time for autoimmune disease diagnostic test result and the high frequency of false positive results.

The European autoimmune disease diagnostic market is basically segmented based on disease type and diagnostics. Based on disease type the market is further segmented as systemic autoimmune disease (rheumatoid arthritis, psoriasis, multiple sclerosis, systemic lupus erythematosus) and localized autoimmune disease (Inflammatory bowel syndrome, Type 1 diabetes, thyroid and others). Based on diagnostics, the market is segmented as Immunofluorescence assays, enzyme linked immnosorbent assay, western blotting, dot blot, line blot, multiplex immunoassay, agglutination, double immune diffusion and counterimmuno electrophoresis.

Based on geographical location, the Europe autoimmune disease diagnostic market can be broadly divided into France, UK, Germany, Spain, Portugal, Scandinavia and Italy.

European Union funded research projects like PRECISESADS and the high prevalence of the disease in Europe are some of the market opportunities for the market players. However, they face the challenge to deal with a shortage of skilled personnel who can operate the technology. The key players are F.Hoffmann-La Roche, Novartis AG, Pfizer Inc., Eli Lilly among many others.

Key Deliverables in the Study

  • Market analysis for the Europe Autoimmune Disease Diagnostic Market, with region specific assessments and competition analysis on regional scales.
  • Market definition along with the identification of key drivers and restraints
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market.
  • Identification and analysis of the macro and micro factors that affect the Europe Autoimmune Disease Diagnostic market on regional scales
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license
Our Clients Include View All

Looking to Customize Report?